Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
China Journal of Chinese Materia Medica ; (24): 2257-2265, 2022.
Article in Chinese | WPRIM | ID: wpr-928167

ABSTRACT

Through literature research and standard retrieval, Corydalis-derived medicinal materials, the origins, and related standards were summarized. Finally, 27 medicinal materials were screened out, involving 71 species(varieties). Among them, only 11 are recorded in Chinese Pharmacopoeia(2020), National Standard for Chinese Patent Drugs·Tibetan Medicine, Tibetan Medicine Standards, and other local standards, including Corydalis Bungeanae Herba and Corydalis Herba. The names and original plants of the medicinal materials are different in different standards, and the phenomena of "same medicinal material with different names" and "same name for different medicinal materials" are prominent. Most standards only include the traits, microscopic identification, and physico-chemical property identification, with unsound quality criteria. Thus, efforts should be made to strengthen the sorting of Corydalis medicinal plants, herbal textual research, and investigation of the resources and utilization. Moreover, via modern techniques, the chemical components and medicinal material basis of different original plants should be explored and sound quality standards should be established to improve the safety and quality of Corydalis-derived medicinal materials. Summarizing Corydalis medicinal plants, Corydalis-derived medicinal materials, and related standards, this study is expected to provide a reference for the standard formulation, quality evaluation, expansion of drug sources, and rational development and utilization of Corydalis resources.


Subject(s)
Corydalis , Drugs, Chinese Herbal/chemistry , Medicine, Chinese Traditional , Medicine, Tibetan Traditional , Plants, Medicinal/chemistry , Reference Standards
2.
Chinese Journal of Experimental Traditional Medical Formulae ; (24): 132-138, 2021.
Article in Chinese | WPRIM | ID: wpr-906373

ABSTRACT

Codonopsis Radix, one of the bulk commodities, has been commonly used for tonification in clinical practice. Apart from the medicinal purpose, it can also be utilized as food. Among the multiple local varieties, the ones called "Luduiduoji" in Tibetan medicine cannot be neglected, which have frequently been adopted for diminishing inflammation and swelling, invigorating spleen and stomach, and tonifying Qi, etc. Considering its complex origins and frequent substitution by or confusion with other medicinal materials, this paper reviewed the Si Bu Yi Dian, Jingzhu Bencao, ministerial and local standards, modern literature on Tibetan medicine, and the results of field investigation in major Tibetan medicine hospitals and medicinal material markets of Sichuan, Qinghai and Tibet to figure out the name, original plants, medicinal parts, effects, and local varieties of Codonopsis Radix in Tibetan medicine. The results showed that the names of local varieties were diverse, many of which were transliterated into Tibetan, with "Luduiduoji" being most well-known. It was derived from 14 species in genus Codonopsis and one in Adenophora of family Campanulaceae, with Codonopsis foetens subsp. nervosa, C. thalictrifolia var. mollis, C. canescens, C. alpina, and C. pilosula being the main species. According to literature records, the roots, aerial parts, and whole plants could all be employed as medicine, but there were certain differences in their clinical applications. At present, in order to protect the medicinal resources, Tibetan medical workers mostly collect the aerial parts, which are applicable to patients with yellow water, rheumatism, Gamba disease, and leprosy. This literature review of local varieties for Codonopsis Radix and textual research on their original plants are of great significance for elevating the standard, accelerating the pharmacodynamic research, expanding the sources and promoting the rational use of Codonopsis Radix.

3.
Chinese Journal of Experimental Traditional Medical Formulae ; (24): 172-180, 2021.
Article in Chinese | WPRIM | ID: wpr-905079

ABSTRACT

Objective:To study the resources and medicinal use of Tibetan medicine Codonopsis canescens,analyze its suitable habitat,and protect its wild resources,in order to provide an important reference basis for further rational development and utilization. Method:Combined investigation methods of literature textual research,visiting investigation and on-the-spot investigation were adopted. Result:In this paper,we investigated the resources and medicinal use of C. canescens in 27 cities and counties of Sichuan,Qinghai and Tibet. Compared with historical records of C. canescens,the results showed that there was no obvious change in the distribution range,and the distribution was uneven in different places. Ganzi Prefecture, Sichuan, boasts rich resources; in particular, Luhuo county has as high as 90-120 plants/100 m2, it is estimated that the reserves per unit area of root C. canescens in this area were 3 445.32 g·m-2,which totaled 1 279.18 ton(1 ton=1 000 kg). In history,the root is the main medicinal part. However, in recent years,in order to protect resources,the aboveground part is frequently used. The clinical efficacy of Tibetan medicine is mainly to tonify Qi and activate blood circulation. It can be combined with other drugs to treat rheumatism,sores,furuncle,carbuncle and other diseases. However,the plants of Codonopsis are mixed with C. canescens in each Tibetan area,and the mixed varieties are determined according to the growing varieties of the same genus in this area. Conclusion:The reserves of wild resources of C. canescens are decreasing with the increase of clinical use and market demand of Tibetan medicine. There is serious mixture of Codonopsis plants in Tibetan areas. It is suggested paying attention to resource protection,carrying out artificial planting,establishing the standard for the medicinal use of Tibetan medicine,and promote rational and sustainable utilization of resources.

4.
Chinese Journal of Contemporary Pediatrics ; (12): 1234-1241, 2021.
Article in English | WPRIM | ID: wpr-922415

ABSTRACT

OBJECTIVES@#To study the effect of levothyroxine sodium tablets on the growth and development and thyroid function in preterm infants with thyroid dysfunction.@*METHODS@#A retrospective analysis was performed for 82 preterm infants who were born in the Department of Obstetrics of the First People's Hospital of Yunnan Province, from January 1, 2013 to December 31, 2017, and these infants were hospitalized after birth in the Department of Neonatology of the hospital. They were regularly followed up to observe growth and development and thyroid function at the outpatient service of the Department of Neonatology. According to thyroid function test results, they were divided into an abnormal thyroid function group (observation group; @*RESULTS@#There were no significant differences in physical development indices (body length, body weight, and head circumference) between the observation and control groups at various gestational ages after follow-up to the corrected age of 12 months (@*CONCLUSIONS@#Early diagnosis and reasonable treatment can reduce the impact on growth and development in preterm infants with thyroid dysfunction. Most preterm infants tend to have transient thyroid dysfunction, while those with positive results of neonatal screening are more likely to develop permanent thyroid dysfunction.


Subject(s)
Female , Humans , Infant , Infant, Newborn , Pregnancy , China , Follow-Up Studies , Gestational Age , Infant, Premature , Pharmaceutical Preparations , Retrospective Studies , Thyroid Gland
SELECTION OF CITATIONS
SEARCH DETAIL